215 related articles for article (PubMed ID: 7104953)
21. [Clinical value of flow cytometry in assessing bone marrow involvement of non-Hodgkin's lymphoma].
Song W; Xie Y; Deng L; Shi Y; Li X; Zheng W; Wang X; Lin N; Tu M; Ying Z; Ping L; Liu W; Zhang C; Ding N; Song Y; Zhu J
Zhonghua Yi Xue Za Zhi; 2014 Oct; 94(38):2996-3000. PubMed ID: 25547702
[TBL] [Abstract][Full Text] [Related]
22. Reviewing histologic diagnosis of lymphoma: comparison of original and review diagnoses in 269 cases.
Woodruff RD
Arch Pathol Lab Med; 1981 Nov; 105(11):573-6. PubMed ID: 7027993
[TBL] [Abstract][Full Text] [Related]
23. [Non-Hodgkin's lymphoma. Cytology and cytochemistry].
Schwarze EW
Veroff Pathol; 1986; 123():1-241. PubMed ID: 3518274
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow involvement in malignant lymphoma without peripheral lymphadenopathy.
Staples WG; Gétaz EP
S Afr Med J; 1977 Jul; 52(2):60-3. PubMed ID: 578338
[TBL] [Abstract][Full Text] [Related]
25. An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation.
Peniket AJ; Ruiz de Elvira MC; Taghipour G; Cordonnier C; Gluckman E; de Witte T; Santini G; Blaise D; Greinix H; Ferrant A; Cornelissen J; Schmitz N; Goldstone AH;
Bone Marrow Transplant; 2003 Apr; 31(8):667-78. PubMed ID: 12692607
[TBL] [Abstract][Full Text] [Related]
26. Flow cytometric S-phase fraction as a complementary biological parameter for the cytological grading of non-Hodgkin's lymphoma.
Pinto AE; Cabeçadas J; Nóbrega SD; Mendonça E
Diagn Cytopathol; 2003 Oct; 29(4):194-9. PubMed ID: 14506670
[TBL] [Abstract][Full Text] [Related]
27. Relation between enzymatic activities and the degree of malignancy of human lymphomas.
Vezzoni P; Giardini R; Raineri M; Pozzi MR; Lucchini R; Vezzoni MA; Clerici L; Besana C; Rugarli C; Rilke F
Eur J Cancer Clin Oncol; 1985 Aug; 21(8):945-50. PubMed ID: 4043177
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
29. DNA content and kinetic characteristics of non-Hodgkin's lymphoma: determined by flow cytometry and autoradiography.
Costa A; Mazzini G; Del Bino G; Silvestrini R
Cytometry; 1981 Nov; 2(3):185-8. PubMed ID: 7297353
[TBL] [Abstract][Full Text] [Related]
30. Hodgkin's disease following non-Hodgkin's lymphoma. A clinicopathologic and immunophenotypic study of nine cases.
Zarate-Osorno A; Medeiros LJ; Kingma DW; Longo DL; Jaffe ES
Am J Surg Pathol; 1993 Feb; 17(2):123-32. PubMed ID: 8422110
[TBL] [Abstract][Full Text] [Related]
31. DNA content in high and intermediate grade non-Hodgkin's lymphoma-prognostic significance and clinicopathological correlations.
Cowan RA; Harris M; Jones M; Crowther D
Br J Cancer; 1989 Dec; 60(6):904-10. PubMed ID: 2605100
[TBL] [Abstract][Full Text] [Related]
32. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
33. DNA content of T-cell lymphomas. A flow-cytometric analysis.
Egerter DA; Said JW; Epling S; Lee S
Am J Pathol; 1988 Feb; 130(2):326-34. PubMed ID: 3257649
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometric evaluation of proliferative activity and ploidy in myelodysplastic syndromes and acute leukemias.
Riccardi A; Montecucco CM; Danova M; Ucci G; Mazzini G; Giordano PA; Pasquali F
Basic Appl Histochem; 1986; 30(2):181-92. PubMed ID: 2427061
[TBL] [Abstract][Full Text] [Related]
35. DNA aneuploidy in Hodgkin's disease: a multiparameter flow cytometric analysis.
Erdkamp FL; Schouten HC; Breed WP; Janssen WC; Hoffmann JJ; Schutte B; Blijham GH
Leuk Lymphoma; 1994 Jan; 12(3-4):297-306. PubMed ID: 8167561
[TBL] [Abstract][Full Text] [Related]
36. DNA image cytometry and the expression of proliferative markers (proliferating cell nuclear antigen and Ki67) in non-Hodgkin's lymphomas.
Czader M; Porwit A; Tani E; Ost A; Mazur J; Auer G
Mod Pathol; 1995 Jan; 8(1):51-8. PubMed ID: 7731942
[TBL] [Abstract][Full Text] [Related]
37. Magnetic resonance imaging of the bone marrow in lymphomas and leukemias.
Tardivon AA; Vanel D; Munck JN; Bosq J
Leuk Lymphoma; 1997 Mar; 25(1-2):55-68. PubMed ID: 9130614
[TBL] [Abstract][Full Text] [Related]
38. Risk of leukemia following treatment for non-Hodgkin's lymphoma.
Travis LB; Curtis RE; Stovall M; Holowaty EJ; van Leeuwen FE; Glimelius B; Lynch CF; Hagenbeek A; Li CY; Banks PM
J Natl Cancer Inst; 1994 Oct; 86(19):1450-7. PubMed ID: 8089863
[TBL] [Abstract][Full Text] [Related]
39. Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma.
Suarez CR; Andreeff M; Miller DR
Med Pediatr Oncol; 1984; 12(2):89-92. PubMed ID: 6583472
[TBL] [Abstract][Full Text] [Related]
40. DNA content analysis of fine needle aspirates obtained from lymphatic tissue.
Alanen KA; Joensuu H; Klemi PJ
Anal Quant Cytol Histol; 1993 Aug; 15(4):259-64. PubMed ID: 8397647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]